Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Michel E, Kuzur"'
Autor:
Michel E. Kuzur, Dianna Shipley, Mathew John Joseph, Laura Blakely, Cassie M. Lane, Mark Mainwaring, Chris Earwood, Johanna C. Bendell, Chandra Reddy, Ronald Blachly, Kirk Barnes
Publikováno v:
Cancer investigation. 35(6)
This phase-2 trial evaluated the efficacy of axitinib as maintenance therapy for patients with metastatic colorectal cancer (mCRC) following first-line treatment with FOLFOX/bevacizumab. Patients with mCRC received mFOLFOX/bevacizumab followed by axi
Autor:
Scott D. Lunin, David R. Spigel, Dianna Shipley, Howard A. Burris, Tiffanie M. Markus, F. Anthony Greco, John D. Hainsworth, Michel E. Kuzur
Publikováno v:
Cancer. 115:2138-2146
BACKGROUND: The authors evaluated the feasibility, toxicity, and efficacy of gefitinib added to first-line combined-modality therapy for patients with locally advanced squamous carcinoma of the head and neck. METHODS: Patients with biopsy-proven loca
Autor:
J. R. Gray, F. Anthony Greco, Howard A. Burris, Michel E. Kuzur, David R. Spigel, Denise A. Yardley, Dianna Shipley, John D. Hainsworth, Jitendra G. Gandhi, D. S. Thompson, Charles D. Webb, Asim Pati
Publikováno v:
Clinical Lung Cancer. 8:483-487
PURPOSE This prospective randomized study compared overall survival (OS) in patients with previously untreated advanced non–small-cell lung cancer (NSCLC) when treated with the platinum agent–based triple drug combination of paclitaxel/carboplati
Autor:
Michel E. Kuzur, David R. Spigel, Kathleen Yost, Eric L. Raefsky, F. Anthony Greco, John D. Hainsworth, Sharlene Litchy, Kommor M
Publikováno v:
Cancer. 104:1992-1997
BACKGROUND The current study was performed to evaluate the activity of combination chemotherapy with gemcitabine and irinotecan in patients with previously treated carcinoma of an unknown primary site. METHODS Patients with carcinoma of an unknown pr
Publikováno v:
Journal of Clinical Oncology. 33:e14673-e14673
e14673 Background: Maintenance therapy is commonly used in the first-line treatment of mCRC. Maintenance therapy options include fluorouracil plus bev and bev single agent. Ax is an oral, potent, a...
Autor:
Suzanne F, Jones, Howard A, Burris, John D, Hainsworth, Denise A, Yardley, Eric A, Raefsky, Fernando T, Miranda, Michel E, Kuzur, Noel T, Willcutt, Melissa B, White, F Anthony, Greco
Publikováno v:
Oncology (Williston Park, N.Y.). 17(5 Suppl 5)
A phase I study of carboplatin (Paraplatin) administered in two different dosing schedules (single dose every 4 weeks and weekly dosing) in combination with weekly irinotecan (CPT-11, Camptosar) was conducted in patients with relapsed or refractory a
Publikováno v:
Cancer. 50:766-774
Endodermal sinus tumor (EST) of the mediastinum is a rare germ-cell neoplasm affecting mainly young adult males. Ten patients with EST were treated with a multimodality approach that included surgery, chemotherapy, and radiotherapy. All patients had
Autor:
John D. Hainsworth, David R. Spigel, Eric L. Raefsky, Michel E. Kuzur, Kathleen Yost, Michael Kommor, Sharlene Litchy, F. Anthony Greco
Publikováno v:
Cancer (0008543X); Oct2005, Vol. 104 Issue 9, p1992-1997, 0p